NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates, “BHG” or “we”), a New York City-based investment fund manager that has inverted its long equity position into that of a short interest in the publicly traded securities of Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), today responded to the Company’s attempt to deny, in its November 11, 2024, press release, the evident product-related fraud at Spectrum Pharmaceuticals, Inc., now wholly-owned by Assertio..

纽约--（商业新闻短讯）--巴克斯顿·赫尔姆斯利集团（连同其某些附属公司，“BHG”或“我们”）是一家总部位于纽约市的投资基金管理公司，已将其长期股权头寸转换为对Assertio Holdings，Inc.（以下简称“Assertio”或“公司”）（纳斯达克：ASRT）公开交易证券的短期股权，今天回应了该公司在2024年11月11日的新闻稿中试图否认Spectrum Pharmaceuticals，Inc.明显与产品相关的欺诈行为。Spectrum Pharmaceuticals，Inc.，现为Assertio全资所有。。

“The statement from Assertio this morning is a blanket response that, tellingly, does not even bother to rebut BHG’s specific allegations—it does not even deny the ‘hush money’ offers to whistleblowers. Instead, the Company is attempting to ‘shoot the messenger’ instead of addressing its failure to properly investigate these matters.

“Assertio今天早上的声明是一个笼统的回应，很明显，它甚至没有反驳必和必拓的具体指控，它甚至没有否认向举报人提供的“沉默费”。相反，该公司试图“射杀信使”，而不是解决其未能正确调查这些问题的问题。

Assertio apparently wishes to continue its evident product-related fraud that, as a byproduct, also appears to be defrauding Assertio investors. In defense of the validity of BHG’s claims, we have released an initial set of evidence so that shareholders and regulators can judge for themselves where the truth lies,” said Alexander Parker, Senior Managing Director of BHG..

Assertio显然希望继续其明显的与产品相关的欺诈行为，作为一种副产品，它似乎也在欺骗Assertio的投资者。BHG高级董事总经理亚历山大·帕克（AlexanderParker）表示：“为了捍卫BHG主张的有效性，我们发布了一套初步证据，以便股东和监管机构能够自行判断真相。”。。

“For example, within the evidence set we have released, shareholders will see a memo from Spectrum’s former Executive Director of Clinical Operations to Spectrum’s former SVP of Clinical Development and former SVP of Clinical Science about a request to delete adverse event data from Spectrum’s database, which is fraudulent conduct.

。

The pages from site audit reports reveal ‘Major’ discrepancies in clinical trial data and cite insufficient training for clinical trial staff. Although whistleblowers sent Assertio’s leadership those site audit reports in private e-mails, Assertio is still issuing statements that say Spectrum’s clinical trials were not ‘Major[ly]’ flawed across multiple products.

。尽管告密者通过私人电子邮件向Assertio的领导层发送了这些现场审计报告，但Assertio仍在发表声明，称Spectrum的临床试验在多种产品中没有“重大缺陷”。

The site audit reports tell the real story, and this is just one example of the full volume of material we will hand over to regulators..

现场审计报告讲述了真实的故事，这只是我们将向监管机构移交全部材料的一个例子。。

“Given the misleading claims from Assertio to date, particularly the claim that the Company investigated the corroborating whistleblower allegations, we call on Mr. O’Grady and the rest of Assertio’s board of directors to release: (i) the full report of its investigation; (ii) documentation that it actually communicated with the whistleblowers; and (iii) documentation confirming it obtained materials from the whistleblowers.

“鉴于Assertio迄今为止的误导性指控，特别是该公司调查了确凿的举报人指控的指控，我们呼吁O'Grady先生和Assertio董事会的其他成员发布：（i）调查的完整报告；（ii）其实际与举报人沟通的文件；以及（iii）证实其从举报人那里获得材料的文件。

Shareholders will note that the investigation, if it ever occurred at all, never collected or reviewed the whistleblowers’ supporting evidence – the Company did not even communicate with the whistleblowers in writing. BHG believes this raises substantial questions about the validity of the investigation’s conclusions and the judgment of the board, which accepted the investigation report..

股东会注意到，如果调查真的发生过，它从未收集或审查举报人的支持证据——公司甚至没有与举报人进行书面沟通。。。

“If the Assertio board’s preferred path is to continue denying the fraud at Spectrum and the pathetically inadequate due diligence leading up to the Spectrum acquisition, we agree with Assertio that regulatory attention is warranted. For its part, BHG is already seeking to engage with the U.S. SEC about these matters, having filed a whistleblower complaint with the agency.

“如果Assertio董事会的首选途径是继续否认Spectrum的欺诈行为以及导致Spectrum收购的令人遗憾的不充分尽职调查，那么我们同意Assertio的说法，即监管部门有必要予以关注。就必和必拓而言，必和必拓已经向美国证券交易委员会（SEC）提交了举报投诉，并已就这些事项寻求与美国证券交易委员会（SEC）接洽。

The materials we are prepared to turn over include the evidence released to stockholders today, supplemented by vast additional material possessed by the Spectrum whistleblowers..

我们准备移交的材料包括今天向股东发布的证据，以及频谱检举人拥有的大量额外材料。。

“The next step will be made by the Assertio board. If they wish to acknowledge reality and pivot to seek to cure the Company and the board’s related liability, we will applaud their decision to reverse course and accept responsibility for past mistakes. If they continue to deny the validity of our evidence-backed assertions, we will continue taking steps to cast light on their considerable evident malfeasance,” concluded Parker..

“断言委员会将采取下一步行动。如果他们希望承认现实，转而寻求纠正公司和董事会的相关责任，我们将赞扬他们改变方向并为过去的错误承担责任的决定。如果他们继续否认我们有证据支持的断言的有效性，我们将继续采取措施，揭露他们明显的渎职行为，”帕克总结道。。

An initial set of the referenced evidence, which has been reviewed by legal counsel, may be found at: https://www.buxtonhelmsley.com/asrt/

经法律顾问审查的第一套参考证据可在以下网址找到：https://www.buxtonhelmsley.com/asrt/

***

***

About Buxton Helmsley

关于巴克斯顿·赫尔姆斯利

The Buxton Helmsley Group, Inc. (“BHG”) is a New York City-based investment advisory firm and fund manager, engaging both active and passive investment strategies across a range of asset classes, with a general focus on opportunities in North America and Europe. The investment approach is based on deep fundamental analysis and risk management, with a focus on ensuring disclosure obligations are being upheld under applicable accounting standards and securities laws..

巴克斯顿赫尔姆斯利集团（BHG）是一家总部位于纽约市的投资咨询公司和基金管理公司，在一系列资产类别中采用主动和被动投资策略，主要关注北美和欧洲的机会。投资方法基于深入的基本面分析和风险管理，重点是确保在适用的会计准则和证券法下遵守披露义务。。

Disclosure: BHG holds a short position in the securities of ASSERTIO HOLDINGS, INC. (NASDAQ:ASRT)

披露：BHG持有ASSERTIO HOLDINGS，INC.（纳斯达克：ASRT）证券的空头头寸

Legal Disclaimer:

法律免责声明：

The use of BHG’s research and analysis is at your own risk. In no event will BHG or any affiliated party be liable for any direct or indirect trading losses caused by any information in this press release. You further must do your own research and due diligence, and consult with your own financial, legal, and tax advisors before making any investment decision with respect to transacting in any securities covered herein.

使用BHG的研究和分析的风险由您自行承担。在任何情况下，必和必拓或任何关联方均不对本新闻稿中的任何信息造成的任何直接或间接交易损失负责。您还必须进行自己的研究和尽职调查，并在就本协议所涵盖的任何证券的交易做出任何投资决策之前，咨询您自己的财务、法律和税务顾问。

You should assume that as of the publication date of this communication, BHG (possibly along with or through our members, partners, affiliates, employees, and/or consultants) has a short position in the stock, bonds, derivatives or securities covered herein, and therefore stands to realize significant gains in the event that the price of the securities of the issuer discussed in this press release declines.

您应该假设，截至本通讯发布之日，BHG（可能与我们的成员、合作伙伴、附属公司、员工和/或顾问一起或通过我们的成员、合作伙伴、附属公司、员工和/或顾问）持有本通讯所涵盖的股票、债券、衍生品或证券的空头头寸，因此，如果本新闻稿中讨论的发行人证券价格下跌，BHG将实现重大收益。

Following publication of this press release, BHG intends to continue transacting in the securities discussed herein, and may be long, short, or neutral at any time thereafter regardless of BHG’s initial position or views. BHG’s investments are subject to its risk management guidance, which may result in the de-risking of some or all of its positions at any time following publication of any report or letter depending on security-specific, market or other relevant conditions.

在本新闻稿发布后，必和必拓打算继续交易本文讨论的证券，并且无论必和必拓的初始立场或观点如何，在此后的任何时候都可能是多头、空头或中性的。必和必拓的投资受其风险管理指南的约束，这可能会导致其部分或全部头寸在发布任何报告或信函后的任何时间降低风险，具体取决于特定证券、市场或其他相关条件。

This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. BHG is registered as an investment advisor with the State of New York.

在任何司法管辖区，如果根据该司法管辖区的证券法，该等要约将不合法，则该等要约不构成出售要约或购买要约的邀约，也不构成向任何人要约或出售任何证券。BHG在纽约州注册为投资顾问。

To the best of BHG’s knowledge and belief, and except as otherwise described herein, all information contained herein is accurate and reliable, and has been obtained from p.

据BHG所知所信，除本文另有说明外，本文所含的所有信息均准确可靠，并已从p。

Cautionary Statement Regarding Forward-Looking Statements:

关于前瞻性声明的警示声明：

The information herein contains “forward-looking statements.” Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “potential,” “targets,” “forecasts,” “seeks,” “could,” “should” or the negative of such terms or other variations on such terms or comparable terminology.

本文中的信息包含“前瞻性陈述”。具体的前瞻性陈述可以通过以下事实来识别：它们不严格与历史或当前事实相关，并且包括但不限于“可能”、“将”、“期望”、“相信”、“预期”、“计划”、“估计”、“项目”、“潜在”、“目标”、“预测”、“寻求”、“可能”、“应该”或此类术语的负面或此类术语或类似术语的其他变化。

Similarly, statements that describe our objectives, plans or goals are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance that any idea or assumption herein is, or will be proven, correct or that any of the objectives, plans or goals stated herein will ultimately be undertaken or achieved.

同样，描述我们的目标、计划或目标的陈述也是前瞻性的。前瞻性陈述受到各种风险、不确定性和假设的影响。无法保证本文中的任何想法或假设是正确的，或者将被证明是正确的，或者本文中所述的任何目标、计划或目标最终将被执行或实现。

If one or more of such risks or uncertainties materialize, or if BHG’s underlying assumptions prove to be incorrect, the actual results may vary materially from outcomes indicated or suggested by these statements. Accordingly, forward-looking statements should not be regarded as a representation by BHG that the future plans, estimates or expectations contemplated will ever be achieved..

如果出现一个或多个此类风险或不确定性，或者如果BHG的基本假设被证明是不正确的，则实际结果可能与这些声明所指示或建议的结果有很大差异。因此，前瞻性声明不应被BHG视为表示未来计划、估计或预期将永远实现。。